Market demands, trends impacting APIs and excipients: MilliporeSigma
An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.
Archives for August 31, 2022
Synthetic bio company Antheia raises $40m, announces new pilot plant
The synthetic biology company which specializes in producing ingredients for plant-inspired medicines has a pilot-scale manufacturing facility in the works.
New WuXi STA plant to tackle growing HPAPI demand
A company leader advises that the growing need for high-potency active pharmaceutical ingredients calls for CDMOs that consistently deliver quality at scale.